C12N 2720/12371
Demonstrated in vivo effect
C12N2720/12371 (Demonstrated in vivo effect) appears on 1 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 1
- Published applications
- 4
- Assignees
- 4
- Inventors
- 19
- Latest grant
- 23 Jan 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Immunogenic composition useful for vaccination against rotavirus15 Feb 2024US 2024/0050555 A1Boehringer Ingelheim Vetmedica GmbH
- Rotavirus mrna vaccine6 Oct 2022US 2022/0313813 A1CureVac AG
- Virus-like particle vaccines30 Jun 2016US 2016/0185826 A1Medigen Biotechnology Corporation
- Tlr5 ligands, therapeutic methods, and compositions related thereto18 Jun 2015US 2015/0165009 A1Emory University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.